Health and Healthcare
Short Sellers, No Direction in Biotech (AMGN, BIIB, CELG, GENZ, GILD)
Published:
It seems that short sellers have no real direction in the major NASDAQ biotech stocks from mid-November to late-November. Generally you see a pattern. This month the only pattern seems to be one of no conviction either way. Here are the short seller reports in the short interest:
Stock (Ticker) NOV. 28 NOV. 14 CHANGE
Amgen Inc. (AMGN) 23,033,081 24,169,278 -4.70%
Celgene Corporation (CELG) 8,298,820 8,040,642 +3.21%
Biogen Idec Inc. (BIIB) 8,027,848 7,938,637 +1.12%
Genzyme Corporation (GENZ) 6,569,181 6,797,501 -3.36%
Gilead Sciences (GILD) 29,055,791 30,213,915 -3.83%
Jon C. Ogg
December 10, 2008
Take This Retirement Quiz To Get Matched With An Advisor Now (Sponsored)
Are you ready for retirement? Planning for retirement can be overwhelming, that’s why it could be a good idea to speak to a fiduciary financial advisor about your goals today.
Start by taking this retirement quiz right here from SmartAsset that will match you with up to 3 financial advisors that serve your area and beyond in 5 minutes. Smart Asset is now matching over 50,000 people a month.
Click here now to get started.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
